Artificial quantum photosynthetic materials

Photosynthesis has been shown to be a highly efficient process for energy transfer in plants and bacteria. It has been proposed that quantum mechanics plays a key role in this energy transfer process. There has been evidence that photosynthetic systems may exhibit quantum coherence. As artificial light-harvesting complexes have been proposed to mimic photosynthesis, it is prudent that artificial photosynthetic materials should also be tested for quantum coherence. To date, such studies have not been reported. In this work, we examine one such system, the BODIPY light harvesting complex (LHC), which has been shown to exhibit classical energy transfer via Förster resonance energy transfer. We compare the photon absorption of the LHC with the BODIPY chromophore by performing UV-visible, transient absorption, broadband pump-probe (BBPP) and two-dimensional electronic (2DES) spectroscopy. The 2DES and BBPP show evidence for quantum coherence, with oscillation frequencies of 100 cm-1 and 600 cm-1, which are attributable to vibronic, or exciton-phonon type coupling. Further computational analysis suggests strong couplings of the molecular orbitals of the LHC resulting from the stacking of neighbouring BODIPY chromophore units may contribute to undesirable hypochromic effects

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

BackgroundWe previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type I IFN, account for 15-20% of cases of life-threatening COVID-19 in unvaccinated patients. Therefore, the determinants of life-threatening COVID-19 remain to be identified in similar to 80% of cases.MethodsWe report here a genome-wide rare variant burden association analysis in 3269 unvaccinated patients with life-threatening COVID-19, and 1373 unvaccinated SARS-CoV-2-infected individuals without pneumonia. Among the 928 patients tested for autoantibodies against type I IFN, a quarter (234) were positive and were excluded.ResultsNo gene reached genome-wide significance. Under a recessive model, the most significant gene with at-risk variants was TLR7, with an OR of 27.68 (95%CI 1.5-528.7, P=1.1x10(-4)) for biochemically loss-of-function (bLOF) variants. We replicated the enrichment in rare predicted LOF (pLOF) variants at 13 influenza susceptibility loci involved in TLR3-dependent type I IFN immunity (OR=3.70[95%CI 1.3-8.2], P=2.1x10(-4)). This enrichment was further strengthened by (1) adding the recently reported TYK2 and TLR7 COVID-19 loci, particularly under a recessive model (OR=19.65[95%CI 2.1-2635.4], P=3.4x10(-3)), and (2) considering as pLOF branchpoint variants with potentially strong impacts on splicing among the 15 loci (OR=4.40[9%CI 2.3-8.4], P=7.7x10(-8)). Finally, the patients with pLOF/bLOF variants at these 15 loci were significantly younger (mean age [SD]=43.3 [20.3] years) than the other patients (56.0 [17.3] years; P=1.68x10(-5)).ConclusionsRare variants of TLR3- and TLR7-dependent type I IFN immunity genes can underlie life-threatening COVID-19, particularly with recessive inheritance, in patients under 60 years old